A recent study found that doubling the dose of Copaxone resulted in a 38% drop in enhancing lesions when compared to the current 20 mg standard dose, though injection-site reactions were worse. Take two, they're small.
Link
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment